# SPANXN2

## Overview
SPANXN2 is a gene that encodes a protein belonging to the SPANX family, specifically the SPANX-N subfamily, which is primarily associated with reproductive processes. The SPANXN2 protein is characterized as a small, disordered protein that localizes to the acrosome of spermatozoa, suggesting its involvement in chromatin remodeling and nuclear condensation during spermatogenesis (Kouprina2007Evolutionary). The gene is located on the X chromosome and contains a minisatellite repeat that may influence the protein's structure and function (Kouprina2007Evolutionary). While SPANXN2 is predominantly expressed in post-meiotic spermatids, it is also found at low levels in various non-gametogenic tissues, indicating potential roles beyond sperm development (Kouprina2007Evolutionary). Despite its evolutionary conservation and expression patterns, the specific functions and clinical implications of SPANXN2, particularly in cancer contexts, remain areas of active research.

## Function
SPANXN2 is a member of the SPANX gene family, which is involved in spermatogenesis. The SPANXN2 protein is expressed in post-meiotic spermatids and localizes to the acrosome of spermatozoa, indicating its role in the later stages of sperm development (Kouprina2007Evolutionary). This localization suggests that SPANXN2 is involved in chromatin remodeling and nuclear condensation during sperm formation, processes critical for proper sperm maturation and fertility (Kouprina2007Evolutionary).

The SPANXN2 gene is part of the SPANX-N subfamily, which is considered the ancestral precursor to the SPANX-A/D subfamily. SPANXN2 proteins are small, disordered proteins that are highly expressed in spermatozoa, unlike the SPANX-A/D proteins, which are cancer-testis antigens expressed only in normal testis and certain tumors (Kouprina2007Mutational). The SPANXN2 protein shares 60-80% identity with other SPANX-N proteins and 40-50% similarity with SPANX-A/D proteins, highlighting its evolutionary diversification and potential functional significance in reproductive biology (Kouprina2007Evolutionary).

SPANXN2 is also expressed at low levels in several non-gametogenic adult tissues, suggesting a broader role beyond spermatogenesis, although its specific functions in these tissues remain to be fully elucidated (Kouprina2007Evolutionary).

## Clinical Significance
SPANXN2 has been studied in the context of various diseases, particularly its role in cancer and pituitary adenomas. In the case of prostate cancer, mutational analysis of SPANXN2 in families with X-linked prostate cancer revealed genetic variants, including one nonsynonymous mutation (T8I) and four synonymous substitutions. However, these variants were not associated with increased susceptibility to prostate cancer, suggesting that SPANXN2 mutations do not have clinical significance in this context (Kouprina2007Mutational).

In pituitary adenomas, SPANXN2 expression levels have been found to be significantly decreased in invasive pituitary adenomas compared to non-invasive ones. This reduction in mRNA levels, approximately four-fold lower in invasive cases, suggests a potential role in the invasive phenotype of these tumors (Lan2016Whole-exome). The decreased expression of SPANXN2, along with other genes, may contribute to the development of an invasive tumor phenotype, although the specific clinical implications of SPANXN2 alone are not fully detailed (Lan2016Whole-exome).

Overall, while SPANXN2 is implicated in certain cancer contexts, its precise role and clinical significance require further investigation.


## References


[1. (Lan2016Whole-exome) Xiaolei Lan, Hua Gao, Fei Wang, Jie Feng, Jiwei Bai, Peng Zhao, Lei Cao, Songbai Gui, Lei Gong, and Yazhuo Zhang. Whole-exome sequencing identifies variants in invasive pituitary adenomas. Oncology Letters, 12(4):2319–2328, August 2016. URL: http://dx.doi.org/10.3892/ol.2016.5029, doi:10.3892/ol.2016.5029. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2016.5029)

[2. (Kouprina2007Mutational) Natalay Kouprina, Vladimir N. Noskov, Greg Solomon, John Otstot, William Isaacs, Jianfeng Xu, Johanna Schleutker, and Vladimir Larionov. Mutational analysis ofspanxgenes in families with x‐linked prostate cancer. The Prostate, 67(8):820–828, March 2007. URL: http://dx.doi.org/10.1002/pros.20561, doi:10.1002/pros.20561. This article has 17 citations.](https://doi.org/10.1002/pros.20561)

[3. (Kouprina2007Evolutionary) Natalay Kouprina, Vladimir N. Noskov, Adam Pavlicek, N. Keith Collins, Pamela D. Schoppee Bortz, Chris Ottolenghi, Dmitri Loukinov, Paul Goldsmith, John I. Risinger, Jung-Hyun Kim, V. Anne Westbrook, Gregory Solomon, Hanna Sounders, John C. Herr, Jerzy Jurka, Victor Lobanenkov, David Schlessinger, and Vladimir Larionov. Evolutionary diversification of spanx-n sperm protein gene structure and expression. PLoS ONE, 2(4):e359, April 2007. URL: http://dx.doi.org/10.1371/journal.pone.0000359, doi:10.1371/journal.pone.0000359. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0000359)